Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1971 1
1974 2
1975 3
1977 2
1979 2
1980 1
1981 1
1983 2
1990 2
1991 1
1992 1
1993 1
1997 1
1998 3
1999 1
2000 4
2001 5
2002 5
2003 6
2004 2
2005 6
2006 7
2007 7
2008 7
2009 14
2010 4
2011 11
2012 21
2013 18
2014 18
2015 18
2016 16
2017 18
2018 15
2019 16
2020 9
2021 8
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

225 results
Results by year
Filters applied: . Clear all
Page 1
Prolyl Hydroxylase Domain Inhibitor Protects against Metabolic Disorders and Associated Kidney Disease in Obese Type 2 Diabetic Mice.
Sugahara M, Tanaka S, Tanaka T, Saito H, Ishimoto Y, Wakashima T, Ueda M, Fukui K, Shimizu A, Inagi R, Yamauchi T, Kadowaki T, Nangaku M. Sugahara M, et al. Among authors: ishimoto y. J Am Soc Nephrol. 2020 Mar;31(3):560-577. doi: 10.1681/ASN.2019060582. Epub 2020 Jan 29. J Am Soc Nephrol. 2020. PMID: 31996409 Free PMC article.
SMPDL3b modulates insulin receptor signaling in diabetic kidney disease.
Mitrofanova A, Mallela SK, Ducasa GM, Yoo TH, Rosenfeld-Gur E, Zelnik ID, Molina J, Varona Santos J, Ge M, Sloan A, Kim JJ, Pedigo C, Bryn J, Volosenco I, Faul C, Zeidan YH, Garcia Hernandez C, Mendez AJ, Leibiger I, Burke GW, Futerman AH, Barisoni L, Ishimoto Y, Inagi R, Merscher S, Fornoni A. Mitrofanova A, et al. Among authors: ishimoto y. Nat Commun. 2019 Jun 19;10(1):2692. doi: 10.1038/s41467-019-10584-4. Nat Commun. 2019. PMID: 31217420 Free PMC article.
225 results